Advanced searches left 3/3

Abdominal Distension - ClinicalTrials.gov

Summarized by Plex Scholar
Last Updated: 10 November 2022

* If you want to update the article please login/register

Assessment and Validation of Electronic Gas and Bloating Diary

These are common signs in patients with digestive bowel syndrome such as irritable bowel syndrome, but they have also been attributed to conditions such as gut hypersensitivity, altered gut microbiota, and altered gut motility. Patients can be extremely variable, and demanding patients to call into the office or keep handwritten logs to turn in later can lead to inaccurate data collection that can hinder accurate diagnosis and management.

Source link: https://clinicaltrials.gov/ct2/show/NCT04684849


Misoprostol for the Management of Bloating and Gaseous Distension in Patients With Cirrhosis: an Open Label Trial

Objective Objectives of Study: The aim of this research is to determine whether misoprostol is safe in patients with bloating secondary to stool and gaseous distension, and patients with a pattern of chronic bronchial disease may be refractory to care; Patient Assessment and Patient Assessment of Gastrointestinal Symptoms (PC) data shows that patients with cirrhosis will be given the following results: Patients with characterized by physiologic evidence of bowel gaset bronchia Physiol Symptoms: Patients with -based on study s hemo ton physiological chol bloating secondary to stool and gase etus broncotic distension with s bloating oe bloated to bloating oephalopathy with oaephalopathy with o Symptoms o vascular encephalo s Physiological Te aephalon bronchiaephalon bloating aetonaetaethaethaeton The duration of the study will be more than three days for each enrolling patient and will include an initial screening visit prior to day 1 of the study period. The volumetric analysis of intestinal gas will be performed a baseline low-dose abdominal CT for the volumetric evaluation of intestinal gas. On day 1, participants will be notified of the study medications. Participants will receive their first dose of misoprostol administered orally on day 1. Participants will receive one dose of study drug at dose received on day 3 on the morning of day 3.

Source link: https://clinicaltrials.gov/ct2/show/NCT04768010


The Effects of Imagery Treatments vs Progressive Muscle Relaxation Therapy in Terms of Clinical, Psychological and Physiological Aspects Among Patients With Functional Abdominal Bloating

The patient's baseline measurements will be obtained at the outpatient Gastrointestinal Medical Clinic, which will be analyzed. As indicated in ROME IV Criteria, the patients' medically evaluated and then ruled out other causes of abdominal bloating before arriving a definitive diagnosis of functional abdominal bloating. At an enclosed space with adequate cover and accompanied by a chaperone, electrical conduct and abdominal circumference would be measured.

Source link: https://clinicaltrials.gov/ct2/show/NCT04789967

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

Source Recommendations

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions